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ABSTRACT
Carotid blowout syndrome (CBS) is a rarely seen complication of 
head-neck surgery and radiation therapy. It may present by massive 
ear bleeding or epistaxis with high morbidity and mortality rates. 
Success rate of endovascular therapy or emergency surgery is 
unfortunately low because of massive bleeding and weakened 
vessel architecture. Here, we present a 45-year-old male with 
nasopharyngeal carcinoma and treated with intensity-modulated 
radiation therapy (IMRT) and concurrent chemotherapy. The 
patient was diagnosed with stage III (T3N2M0) carcinoma of the 
nasopharynx. Eight months after radiotherapy, he was admitted 
to hospital with the complaint of epistaxis. Right internal carotid 
angiography revealed a 4 mm pseudoaneurysm at the superior-
anterior wall of the petrous and his bleeding was controlled by 
stenting in the same session. In this report we aimed to draw 
attention to this rare clinical situation that might enhance the chance 
of early diagnosis enabling less morbid treatment opportunities.
Keywords: IMRT, Carotid blowout syndrome, CBS, 
Pseudoaneurysm
ÖZ
Carotid blowout sendromu (CBS) veya pseudoaneurysm, 
baş-boyun cerrahisi ve radyoterapi sonrası nadir görülen bir 
komplikasyondur. Yüksek morbidite ve mortalite oranları ile masif 
kulak kanaması veya epistaksis şeklinde görülür. Zayıflamış damar 
yapısı ve masif kanama sebebiyle acil cerrahi ya da endovasküler 
tedavilerin başarı şansı oldukça düşüktür. Bu yazıda, nazofarenks 
kanseri tanısı olan ve eş zamanlı kemoterapi ile beraber yoğunluk 
ayarlı radyoterapi (YART) C alan 3. evre (T3N2M0), 45 yaşında 
erkek hasta sunulmuştur. Radyoterapi sonrası 8. ayda epistaksis 
ile hastaneye başvuran hastanın sağ internal carotis arter 
anjiografisinde petros segmentin antero-superior duvarında 4mm 
pseudoanevrizma saptanıp aynı seansta stentle kanama kontrolu 
yapılmıştır. Bu yazıda, erken tanı konulabilmesi ve dolayısıyla 
daha az morbid tedavi seçeneklerinin sunulabilmesi için nadir 
görülen bu klinik duruma dikkat çekilmesi amaçlanmıştır.
Anahtar kelimeler: YART, Carotid blowout sendromu, CBS, 
Pseudoanevrizma
Introduction
Pseudoaneurysm, rupture of the carotid artery, or carotid 
blowout syndrome (CBS) is a rare complication of head 
and neck surgery and radiotherapy. Mostly after re-
irradiation, a cascade of reactions occurs in the endothelial 
cells which causes disruption of the arterial wall leading to 
pseudoaneurysms. Herein, we report a nasopharyngeal cancer 
(NPC) patient who was diagnosed as CBS, 8 months after 
chemoradiotherapy and treated with stent implantation [1].
Case Report
A 45-year-old man referred to our department with the 
diagnosis of undifferentiated NPC in April 2013. His 
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magnetic resonance imaging (MRI) scan revealed a 
nasopharyngeal mass lesion which invaded the base of 
the skull bones and posterior wall of the right maxillary 
sinus with bilateral pathologic level IIB lymph nodes. His 
positron emission tomography – computed tomography 
(PET-CT) scan revealed a nasopharyngeal primary tumor 
with bilateral level II metastatic lymph nodes and no distant 
metastasis. Thus, he was staged as T3N2M0 - Stage III. His 
pretreatment plasma Epstein-Barr virus (EBV) DNA level 
was 18.370 cp/ml before the treatment.
Between, 3 September 2013 and 22 October 2013, the 
patient was treated with concomitant chemoradiotherapy 
using 3-weekly cisplatinum. Radiotherapy was applied 
by using volumetric modulated arc treatment with 6 MV 
photons. Simultaneous integrated boost technique was used 
to give a total dose of 6990 cGy to the nasopharyngeal 
primary, retropharyngeal lymphadenopathy and all gross 
nodal disease, 6000 cGy to the entire nasopharynx (includes 
retropharyngeal lymph nodal regions, clivus, skull base, 
pterygoid fossae, parapharyngeal space, inferior sphenoid 
sinus and posterior third of the nasal cavity and maxillary 
sinuses), bilateral upper neck node regions and 5600 cGy 
to the supraclavicular lymph nodes in 33 fractions. Grade 
2 mucositis, dermatitis, esophagitis, local alopecia, and 
neutropenia developed during treatment. One month after 
treatment his plasma EBV DNA level was found to be 
negative. His follow-up PET-CT revealed partial response at 
nasopharynx and complete response at nodal disease, however, 
skeletal metastasis developed at thoracal vertebras and pelvic 
bones 3 months after concomitant chemoradiotherapy. His 
plasma EBV DNA level at recurrence was 1.352 cp/ml. He 
received one cycle of combined Taxotere – Cisplatin – 5Fu 
(TPF) (Taxotere – Cisplatin – 5Fu) chemotherapy but he 
refused to get chemotherapy thereafter.
Eight months after the termination of radiotherapy he 
admitted to our hospital with the complaint of epistaxis. 
It was learnt that minimal epistaxis had been present 
for a few week before presentation. Otolaryngological 
examination revealed oozing type of epistaxis originating 
from nasopharyngeal region. Initially, simple transnasal 
tamponade was inserted and red blood cell transfusions 
were given. Under general anesthesia, bilateral external-
internal carotid digital substraction angiography (DSA) was 
performed. Right internal carotid angiographies revealed 
a 4 mm pseudoaneurysm at the superior-anterior wall of 
the petrous segment (Figure 1). Because of poor cross-
flow through the circle of Willis, parent artery protection 
Figure 1: Right internal carotid artery DSA; white arrows are 
showing pseudoaneurysm in the petrous segment.
Figure 2: Right internal carotid artery DSA after stent-graft 
implantation; white arrows showing patency of the parent artery 
and lack of filling of the pseudoaneurysm with good reconstruction.
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was needed. The patient received a loading dose of 
clopidogrel through the nasogastric tube in the operating 
room and implantation of a drug eluded stent (Be Graft 
5x22mm) was performed in the same session. Control DSA 
demonstrated closure of the pseudoaneurysm and bleeding 
was controlled successfully (Figure 2). Following removal 
of nasal bandages intraoperatively, repeat DSA showed 
absence of filling of pseudoaneurysm and no nasal bleeding 
was observed. After stent implantation no neurological 
complication was observed, antithrombotic therapy was 
continued. The patient is still alive with disease.
Discussion
Pseudoaneurysm rupture of the carotid artery, or CBS is a 
rare but dreadful complication of head and neck surgery 
and/or radiotherapy. In a recent review by Powitzky et al., 
clinicopathologic features of CBS in patients with head and 
neck cancer was evaluated. They performed a retrospective 
review of all studies documenting 132 CBS cases with head 
and neck cancer from 21 studies. They found that patients 
with CBS typically have a history of radiotherapy (89%), 
nodal metastasis (69%), and neck dissection (63%). They 
indicated that morbidity and mortality rates of patients 
with CBS are significant; only 23% have survived. Almost 
50% of the CBS patients presented with sentinel bleeding, 
but other half of patients developed a life-threatening 
hemorrhage requiring emergent intervention [2].
Acute carotid rupture occurs when a compromised 
arterial wall cannot maintain its integrity against relatively 
high blood pressure. Disruption of the integrity of the arterial 
wall may be caused by direct involvement of malignancy, 
by infection of fistula or an abscess, by loss of overlying 
soft tissue, or by desiccation effects of skin involvement, 
or by apoptotic and inflammatory reaction of radiotherapy 
causing vascular endothelial damage, or by combination 
of these factors [3]. Some of the predisposing factors that 
can lead to CBS include radiation, surgery, trauma, diabetes 
mellitus, poor nutrition, prolonged corticosteroid use, 
and uncontrolled hypertension [4]. As our presented case, 
was treated only with radiotherapy and chemotherapy, we 
believe that formation of this pseudoaneurysm was due to 
the treatment as there were no any other aforementioned 
predisposing factors which may lead to this complication.
Carotid blowout syndrome was a very rare event 
during the 3-D conformal radiotherapy era. Bleeding was 
also reported rarely after inensity-modulated radiotherapy 
(IMRT) treatment in the literature. Simultaneous integrated 
boost (SIB) technique is commonly used in patients 
treated with head and neck IMRT. This technique allows 
for improved dose differential by administering different 
fractional doses to different targets in the same treatment. 
SIB is a new accelerated fractionation schedule for the 
treatment of head-and-neck cancer with IMRT. Thus, 
besides physical dose escalation in the tumor, a biologic 
effect of accelerated fractionation can occur within tumor 
also. Lee et al., reported bleeding rate of 1.5% and death 
rate of 1.5% in median follow up of 2.6 years in patients 
treated with IMRT. Only one patient died of uncontrolled 
epistaxis approximately 6 months after completion of IMRT; 
however, the cause of death was not defined [5]. Kwong et 
al., reported bleeding rate of 4% and no death was reported 
in median follow up of 2.1 years. Two patients developed 
carotid pseudoaneurysm - one received both IMRT and 
subsequent stereotactic radiosurgery for persistent disease 
in nasopharynx and the other patient received IMRT and 
chemotherapy. Both patients presented with sudden onset 
of torrential epistaxis at about 7 months after completion 
of IMRT. Emergency surgical intervention successfully 
controlled the bleeding pseudoaneurysm in both cases [6]. 
Lin et al., reported bleeding rate of 0.3% and death rate of 
0.6%. [7]. All three series who reported CBS treated their 
patients using SIB technique and their prescription dose to 
the primary tumor ranged between 2.12-2.25 Gy, 2.17 Gy 
and 2.2-2.25 Gy and total dose ranged between 65-70 Gy, 
76 Gy and 66-70 Gy, respectively. It is well known that SIB 
technique may cause maximum doses in the target which 
exceeds >110% to 120% of the prescribed dose. According 
to Radiation Therapy Oncology Group (RTOG) 0225 
nasopharyngeal cancer protocol, if greater than 5% of the 
PTV70 receives greater than 115% of prescribed dose, this 
situation is scored as major variation and these patients were 
considered noncompliant to the study [5].
In our patient, we tried to identify the maximum dose 
received for the superior-anterior wall of petrous segment 
of the right internal carotid artery (ICA). We made a fusion 
of treatment planning CT and post stent CT to document 
this high dose area (Figure 3). This dose ranges between 
7350 cGy to 7969 cGy (105% to 113% of the prescribed 
dose). Mc Donald et al., reported that increasing the daily 
dose with hypofractionation would cause 3-fold increase 
incidence of CBS. In this case, high dose concentration with 
SIB technique could be the most enhancing causative factor 
for the development of the pseudoaneurysm [4].
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Although, IMRT and stereotactic body radiation therapy 
(SBRT) techniques are designed to minimize the dose of the 
radiation for the healthy tissue surrounding the tumor, we 
currently have little feedback on early and late toxicity of 
these techniques. This is mainly due to limited data including 
long term follow-up and to less precise knowledge of the 
radiobiology of high doses of radiation. The conventionally 
used model for predicting tumor response and normal 
tissue toxicity is the cell survival lineer quadratic model. 
This model is essentially based on repair and death 
mechanism related to radiation induced DNA damage [8]. 
However, other molecular mechanisms may be involved in 
the normal tissues other than cancer cell cultures. Among 
these pathways, the microvascular endothelial compartment 
has been shown to play a major role in radiation toxicity. 
Radiation levels above 10 Gy cause endothelial cells 
to enter apoptotic cell death ending with damage to the 
microvascular network. After apoptosis surviving cells 
secrete excessively pro-inflammatory cytokines causing 
activation of the coagulation system and increased vascular 
permeability. Late effects include microvascular collapse 
and thickening of the basement membrane and distruption 
of the normal architecture of the vessel wall. Dose escalation 
by using IMRT and SBRT techniques may lead to a different 
mechanism. Acid sphingomyelinase (ASMase)/ ceramide 
pathway requires more than conventional doses to be 
activated. It was shown that this pathway was not triggered 
in tissues exposed to conventional fractionated radiotherapy. 
These alternative pathways would be causative factors 
which lead to unexpected clinical results of the high doses 
by using IMRT and SBRT techniques [3].
While CBS incidence is very low after postoperative or 
definitive radiotherapy, this risk significantly increases in 
patients treated with re-irradiation or subsequent stereotactic 
radiosurgery boost for persistent disease after definitive 
radiotherapy. Local recurrence after definitive radiotherapy 
remains a major issue and nasopharynx is the most suitable 
site for re-irradiation. However, anatomic location and need 
for a high dose irradiation make this treatment extremely 
challenging. Conventional radiotherapy produced less 
optimal outcome and was associated with high rate of 
late toxicity. IMRT is a better strategy with better dose 
distribution. One year local control ranged between 44%-
100% depending on T stage in the literature. However, Grade 
III toxicity rate ranged between 19% to 36%. [9,10,11] Tian 
Figure 3: Axial view ; the relationship of the pseudoaneurysm with high dose area (Purple Line: Stent ; Colour wash illustration shows 105 
% of the prescribed dose )
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et al., reported their experience in patients with locally 
recurrent nasopharyngeal carcinoma treated with IMRT in 
a phase 2 randomized controlled trial. They reported that 
hypofractionation increasing dose per fraction from 200 
cGy to 222 cGy causes significantly higher incidences of 
mucosal necrosis and hemorrhage (from 28.8% to 50.8%) 
and lower overall survival (44.2% vs 30.3%) [12]. Similarly 
Yamazaki et al., informed increased risk for CBS by 
enhanced dose concentration and high BED values [13]. 
In our case, time between radiotherapy and the CBS is 8 
months. In the literature, this duration varies from during 
radiotherapy to 17 years, but CBS was mostly seen in a year 
after radiotherapy. This variation suggests the possibility 
of having different pathways of underlying pathologic 
processes [4].
Stereotactic radiosurgery with single high dose radiation 
or stereotactic radiotherapy using high dose per fraction 
are other strategies for re-irradiation. Cranial neuropathy, 
trismus, epistaxis, temporal lobe necrosis, osteoradionecrosis 
and fatal CBS are among the late complications. Recently, 
Cengiz et al., reported 46 recurrent, unresectable, and 
previously irradiated head-and-neck cancer patients treated 
using robotic hypofractionated radiotherapy. Their median 
tumor dose was 30 Gy in a median of five fractions. One-
year progression-free survival and overall survival were 
41% and 46%, respectively. They reported Grade II or 
greater long-term complications rate of 13.3%. However, 
they also reported that 8 (17.3%) patients developed CBS 
on follow-up, and 7 (15.2%) patients died because of 
bleeding of the carotid arteries. They discovered that CBS 
occurred only in patients with tumor surrounding carotid 
arteries and carotid arteries receiving all prescribed dose. 
Authors, changed their treatment protocol due to the high 
rate of CBS, treated following 32 patients every other day in 
a prospective protocol. Three out of 32 patients developed 
CBS with the new treatment strategy with relatively short 
follow up time. They also mentioned that CBS did not 
occur in any of the patients with a maximum carotid artery 
radiation dose of <34 Gy [15].
Carotid blowout syndrome was historically observed 
among patients who had recurrent disease after re-irradiation 
or salvage surgery. However, with more aggressive primary 
treatment, we may observe more of this complication in 
the future. Excessive doses in the planning target volume 
(PTV) should be avoided in the absence of gross tumor 
volume. Also, clinicians need to be aware of this potential 
complication in patients who present with severe epistaxis 
after treatment. Patients who are at high risk for CBS 
should be followed by MRI angiography beside routine 
MRI. Emergency resuscitation and interventions should be 
applied in these patients.
As a consequence; CBS is a rarely seen complication of 
head and neck surgery and radiation therapy. It may present 
by massive ear bleeding or epistaxis with high morbidity 
and mortality rates. Success rate of endovascular therapy or 
emergency surgery is unfortunately low because of massive 
bleeding and weakened vessel architecture. In this case-
report we aimed to draw attention to clinical changes in 
patients after radiation therapy that may alert clinicians and 
elective angiography after local therapies of head and neck 
surgery might enhance the chance of early diagnosis that 
enables less morbid treatment opportunities.
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